Skip to content

Clinical trials

Terminated Fallopian Tube Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Status: Terminated Country / region: Canada Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20101
20111
20121
20171
20181
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Gynecologic Oncology Group1
Mersana Therapeutics1
Mural Oncology, Inc1
Pfizer1
SWOG Cancer Research Network1
Seagen, a wholly owned subsidiary of Pfizer1
Sumitomo Pharma America, Inc.1
Sutro Biopharma, Inc.1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms11
Ovarian Neoplasms11
Carcinoma, Ovarian Epithelial5
Triple Negative Breast Neoplasms2
Breast Neoplasms1
Breast Neoplasms, Male1
Brenner Tumor1
Carcinoma, Adenoid Cystic1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.